pharma · No medical condition. · Breast cancer
George Institute for
The George Institute
George Institute for clinical programs — 94 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Sydney, NSW 2042, AU
- Founded
- 1999
- Employees
- 841
- Programs
- 406
- Drugs
- 522
- Patents
- 0
George Institute for projects
94 ClinicalTrials.gov programs sponsored by George Institute for.
George Institute for has 94 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
KEEP-ON
The George Institute
Hyperkalemia in patients with chronic kidney disease
1 trial -
Levetiracetam NORMON comprimidos recubiertos...
The George Institute
Down syndrome, Alzheimer's Disease
1 trial -
METHYLPREDNISOLONE , ACETYLCYSTEINE
The George Institute
Acute Alcoholic hepatitis
1 trial -
MHICC-2021-001
The George Institute
Type 2 diabetic patients with no prior cardiovascular (CV) events
1 trial -
Metformina Uxa comprimidos recubiertos con pe...
The George Institute
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Mirena 20 mikrogram/24 timmar intrauterint in...
The George Institute
Post medical abortion contraception
1 trial -
Natriumklorid Braun /ml spädningsvätska för p... for Allergisk Rinit
The George Institute
Allergisk Rinit
1 trial -
Niraparib tosylate monohydrate + abiraterone... for Prostate Cancer
The George Institute
Prostate Cancer
1 trial -
P01351
The George Institute
Chronic kidney disease
1 trial -
P01351
The George Institute
Chronic Kidney Disease
1 trial -
PI23/00797
The George Institute
Acute Heart Failure
1 trial -
PROICM 2018-01 NEX
The George Institute
Metastatic colorectal cancer
1 trial -
PROICM 2021-01 GRE
The George Institute
Rectum cancer
1 trial -
Placebo capsules for bacterial sexually transmitted…
The George Institute
bacterial sexually transmitted infections
1 trial -
RAMIRIS
The George Institute
advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions, who failed prior line of palliative chemotherpay
1 trial -
REACT
The George Institute
Community-acquired pneumonia
1 trial -
RESPIRATORY SYNCYTIAL VIRUS VACCINES
The George Institute
RSV infection
1 trial -
Rabipur Pulver und Lösungsmittel zur Herstell... for Rabies
The George Institute
Rabies
1 trial -
Rabipur poeder en oplosmiddel voor oplossing... for Rabies
The George Institute
Rabies
1 trial -
Rivaroxaban 2.5 Mg Oral Tablet
The George Institute
Chronic Kidney Diseases
1 trial -
S005201-175
The George Institute
Type 2 Diabetes inadequately controlled with dapagliflozin with or without metformin
1 trial -
S095031-178
The George Institute
Hypomethylating agent (HMA) naive myelodysplastic syndromes Myelodysplastic Symdrome (MDS), Myelodysplastic Symdrome (MDS)
1 trial -
SATURN
The George Institute
Spontaneous lobar ICH
1 trial -
SEVOFLURANE, DEXMEDETOMIDINE HYDROCHLORIDE
The George Institute
Children under the age of 2 years having surgery lasting at least 2 hours
1 trial -
SHIELD-PRP
The George Institute
CHRONIC OMALGIA
1 trial -
SIMFIB
The George Institute
Fibrosis liber, chronic liver disease, alcoholic liver disease
1 trial -
SMART-JIA
The George Institute
Juvenile Idiopathic Arthritis
1 trial -
STAMARIL® for Yellow fever
The George Institute
Yellow fever
1 trial -
STEMNESS-CRC
The George Institute
Histologically confirmed adenocarcinoma of the colon or rectum that is metastatic.
1 trial -
STEMNESS-PANC
The George Institute
Histologically or cytologically confirmed advanced pancreatic adenocarcinoma that is metastatic.
1 trial -
Skilarence gastro-resistant tablets for Adrenomyeloneuropathy
The George Institute
Adrenomyeloneuropathy
1 trial -
Suspension of autologous mononuclear cells separated from bone marrow aspirate
The George Institute
diabetic foot syndrome, lower limb ischemia
1 trial -
TRACK_001
The George Institute
Improvement of cardiovascular outcomes in patients with advanced chronic kidney disease. In easily understood language, this is Heart and blood vessel disease and Kidney disease.
1 trial -
TRIGON DEPOT 40 mg/ml suspensión inyectable.
The George Institute
Chronic shoulder pain
1 trial -
TROMALYT 150 mg cápsulas duras de liberación prolongada
The George Institute
Women infertility
1 trial -
Tamoxifen Viatris 20 mg tabletter.
The George Institute
Breast Cancer
1 trial -
Testosterone Gel 1% for low ovarian reserve according t…
The George Institute
low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
1 trial -
The STARS trial
The George Institute
juvenile idiopathic arthritis
1 trial -
The placebo tablet composition is: Collodial...
The George Institute
Colon and rectal cancer tumor stage II-III, tumor with somatic alterationsin PIK3CA, PIK3R1 or PTEN
1 trial -
Tibsovo 250 mg film-coated tablets
The George Institute
ivosidenib maintenance after SOC adjuvant chemotherapy in curative mIDH1 cholangiocarcinoma
1 trial -
Trulicity 0.75 mg solution for injection in pre-filled pen
The George Institute
Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation
1 trial -
Trulicity 0.75 mg solution for injection in pre-filled pen
The George Institute
Preventive treatment of post-kidney transplant diabetes
1 trial -
URONCOR 06-24
The George Institute
Prostate Cancer
1 trial -
VACAB-2022
The George Institute
Patients with hip or knee infections
1 trial -
Vanish Trial
The George Institute
People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.
1 trial -
imPaCT-PRO-01
The George Institute
Thromboprophylaxis in patients with advanced pancreatic cancer
1 trial
Frequently asked questions
How many clinical projects does George Institute for have?
94 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.